Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VERTEX PHARMACEUTICALS INC Key Ratios

  • Valuation Ratio: VRTX

    P/E (TTM) -9.29
    Price to CashFlow -12.92
    Price to Sales (TTM) 24.33
    Price to Book 11.26
  • Per Share Ratio: VRTX

    Dividend Per Share (TTM) 0.00
    Book Value Per Share -1.28
    EPS Fully Diluted -3.27
    Revenue Per Share 1.25
  • 5 Year Annual Growth: VRTX

    Net Income
    Revenue 20.48%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: VRTX

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: VRTX

    Operations Margin -261.18%
    Net Profit Margin -262.02%
    Gross Profit Margin 72.72%
  • Financial Strength: VRTX

    Quick Ratio (MRQ) 3.95
    Current Ratio (MRQ) 3.95
    LT Debt to Equity (MRQ) 43.18
    Total Debt to Equity (MRQ) 43.18
    Return on Equity (ROE) Per Share -180.61
    Return on Assets (ROA) -46.95
    Return on Invested Capital (ROIC) -110.34
  • Assets: VRTX

    Asset Turnover 0.18
    Inventory Turnover